NextPlat Corp
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- NextPlat Corp (Nasdaq: NXPL) operates as a global consumer products and services company focused on healthcare and technology solutions delivered through e-commerce platforms, retail channels, and specialized divisions worldwide. The company offers satellite-enabled communications services including voice, data, tracking, and IoT solutions through brands such as Global Telesat Communications, Orbital Satcom, and Outfitter Satellite, partnering with network operators like Iridium, Globalstar, and Starlink; provides pharmacy and healthcare services via subsidiary Progressive Care Inc. and PharmcoRx, encompassing full-service retail and specialty pharmacies, prescription pharmaceuticals, third-party administration, risk and data management with ClearMetrX analytics platform, compounded medications, tele-pharmacy, anti-retroviral medications, medication therapy management, adherence packaging, long-term care supplies, 340B support, and OTC benefits; distributes OPKO Health products exclusively in China for human and animal healthcare; and sells its Florida Sunshine brand of premium liposomal vitamins supporting immunity, energy, and heart health across Europe, North America, and with initial China approval. NextPlat conducts e-commerce operations across 30 storefronts, marketplaces including Amazon, Walmart, and Alibaba, and retail locations, serving over 150,000 customers in 160-plus countries spanning Europe, North America, South America, Asia-Pacific, Africa, and other regions from headquarters in Coconut Grove, Florida. Recent developments include the October 2024 completion of its merger with Progressive Care Inc. integrating healthcare operations; September 2025 launch of Florida Sunshine vitamins internationally and ClearMetrX 4.0 AI-enhanced analytics software for internal Q4 2025 rollout and 2026 commercialization; appointment of Rodney Barreto as Chairman and David Phipps as CEO in September 2025 alongside leadership additions like Birute Norkute as VP Healthcare Operations and Amanda L. Ferrio as CFO in October 2025 to drive refocusing; November 2025 multi-state prescription fulfillment contract award; headquarters consolidation and cost reductions targeting $2 million annual savings; satellite distribution growth over 170% year-over-year with 50,000-plus hardware units sold; and a Nasdaq 180-day bid price compliance extension granted in October 2025.
Company News
NextPlat Reports 21% Sequential Quarterly Revenue Growth, 87% Reduction in Quarterly Net Loss to $144,000 and Record Gross Margin of Approximately 40%
NextPlat to Release Second Quarter 2026 Results on Thursday, August 13, 2026
NextPlat Delivers Mid-Year 2026 Shareholder Update Confirming Strong Growth and Profitability Outlook
NextPlat's PharmcoRx Earns NABP Specialty Pharmacy Accreditation Strengthening its Credentials for New Opportunities with Healthcare Institutions and Providers
NextPlat to Acquire Pensacola-Area Pharmacy, Expanding Florida Footprint and Adding Approximately $5.6 Million in Profitable Annual Revenue
NextPlat Reports $9.9 Million in Revenue for Q1 2026 with Record Quarterly Consolidated Gross Margins of 35%
NextPlat to Release First Quarter 2026 Results on Thursday, May 14, 2026
NextPlat Expects Q1 2026 Gross Margins to Jump to 34+%, Operating Expenses to Decline 8+% From Q4 2025 and Achieve Positive Operating Income in Q3
NextPlat Regains Compliance with Nasdaq Bid Price Requirement
NextPlat's PharmcoRx Deploys Artificial Intelligence-Powered Prescription Processing Technology Supporting Expanded Nationwide Fulfillment Efforts
NextPlat's GTC Receives Satellite Enabled Internet of Things (IoT) Contracts Valued at $400,000 as its Government and Military Pipeline Surpasses $1.2 Million Through Q1 2026
NextPlat Announces 1-for-10 Reverse Stock Split to Be Effective Prior to Market Open on April 13, 2026
NextPlat (NASDAQ:NXPL) Shares Scheduled to Reverse Split on Monday, April 6th
NextPlat Reports $54 Million in Revenue for Full Year 2025 as Business Turnaround Initiatives Support Operational Profitability Goals in 2026
Head-To-Head Contrast: NextPlat (NASDAQ:NXPL) versus Akso Health Group (NASDAQ:AHG)
NextPlat Announces Reverse Stock Split to Regain Compliance with Nasdaq's Bid Price Requirement
NextPlat Launches 50 State Nationwide Medication Fulfillment Capabilities, Supporting Healthcare Revenue Growth in 2026 and Beyond
NextPlat to Release Full Year 2025 Results on Tuesday, March 31, 2026
NextPlat (NASDAQ:NXPL) vs. ARTISTdirect (OTCMKTS:ARTD) Financial Survey
Financial Contrast: NextPlat (NASDAQ:NXPL) vs. Akso Health Group (NASDAQ:AHG)